| AC | astrocyte cell |
| ADCC | antibody-dependent cellular cytotoxicity |
| ADCP | antibody-dependent cellular phagocytosis |
| BBD | beclin 1 binding domain |
| BMP4 | bone morphogenetic protein 4 |
| CSC | cancer stem cell |
| DGC | differentiated glioblastoma cell |
| DSB | double-strand DNA break |
| E | early |
| ED50 | median effective dose |
| EGFR | epidermal growth factor receptor |
| GBM | glioblastoma |
| GEM | genetically engineered mouse |
| GSC | glioblastoma stem-like cell |
| h | human |
| HGG | high-grade glioma |
| HDAC | histone deacetylase |
| m | mouse |
| ICI | Immune checkpoint inhibitor |
| IDH | isocitrate dehydrogenase |
| IE | immediate early |
| L | late |
| MES | mesenchymal |
| MGMT | O6-methylguanine-DNA methyltransferase |
| MOI | multiplicity of infection |
| MRI | magnetic resonance imaging |
| oHSV | oncolytic herpes simplex virus |
| OPC | oligodendrocyte progenitor cell |
| OV | oncolytic virus |
| PDX | patient-derived xenograft |
| PARP | poly(ADP-ribose) polymerase |
| pfu | plaque forming unit |
| RR | ribonucleotide reductase |
| ScGC | serum-cultured GBM cells |
| TGFβ | transforming growth factor-β |
| TGFβ receptor | TGFβ |
| TIL | tumor-infiltrating lymphocytes |
| TK | thymidine kinase |
| TME | tumor microenvironment |
| TMZ | temozolomide |
| Treg | T regulatory cell. |